Alexandre Acramel

Paris, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Reducing waiting time of injectable anticancer drug preparations in day care oncology units: A summary of evidence, implemented strategies, and perspectives for hospital pharmacists.

Reducing waiting time of injectable anticancer drug preparations in day care oncology units: A summary of evidence, implemented strategies, and perspectives for hospital pharmacists.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: February 18, 2026

Antinociception and neuroprotection of the peptidic G protein-coupled estrogen receptor inverse agonist PLMI in the murine model of paclitaxel-induced peripheral neuropathy.

Antinociception and neuroprotection of the peptidic G protein-coupled estrogen receptor inverse agonist PLMI in the murine model of paclitaxel-induced peripheral neuropathy.

Journal: British journal of pharmacology

Published: October 08, 2025

Trabectedin in the treatment of soft tissue sarcoma: Real-world data on effectiveness, safety, and financial implications from a European comprehensive cancer center.

Trabectedin in the treatment of soft tissue sarcoma: Real-world data on effectiveness, safety, and financial implications from a European comprehensive cancer center.

Journal: International journal of cancer

Published: August 28, 2025

Gravimetric-based technology-assisted workflow system for injectable anticancer drugs compounding: Design and qualification of an original weighing scale anchored inside an isolator.

Gravimetric-based technology-assisted workflow system for injectable anticancer drugs compounding: Design and qualification of an original weighing scale anchored inside an isolator.

Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners

Published: March 13, 2025

Sacituzumab govitecan in metastatic triple-negative breast cancer patients treated at Institut Curie Hospitals: efficacy, safety, and impact of brain metastases.

Sacituzumab govitecan in metastatic triple-negative breast cancer patients treated at Institut Curie Hospitals: efficacy, safety, and impact of brain metastases.

Journal: Breast cancer (Tokyo, Japan)

Published: November 29, 2023

GPER involvement in inflammatory pain.

GPER involvement in inflammatory pain.

Journal: Steroids

Published: July 21, 2023

Advanced prescription of injectable anticancer drugs: Safety assessment in a European Comprehensive Cancer Centre using the risk matrix approach.

Advanced prescription of injectable anticancer drugs: Safety assessment in a European Comprehensive Cancer Centre using the risk matrix approach.

Journal: British journal of clinical pharmacology

Published: February 25, 2023

Errors in prescribing injectable anticancer drugs: benefits of a pharmaceutical long-term monitoring to improve patient safety in a European comprehensive cancer centre.

Errors in prescribing injectable anticancer drugs: benefits of a pharmaceutical long-term monitoring to improve patient safety in a European comprehensive cancer centre.

Journal: European journal of hospital pharmacy : science and practice

Published: January 02, 2023

Reporting environmental contamination results to healthcare workers could play a crucial role in decreasing the risk of occupational exposure to antineoplastic drugs.

Reporting environmental contamination results to healthcare workers could play a crucial role in decreasing the risk of occupational exposure to antineoplastic drugs.

Journal: Frontiers in public health

Published: June 09, 2022

Deciphering of a Putative GPER Recognition Domain in ERα and ERα36.

Deciphering of a Putative GPER Recognition Domain in ERα and ERα36.

Journal: Frontiers in endocrinology

Published: May 13, 2022

Identification of a human estrogen receptor α tetrapeptidic fragment with dual antiproliferative and anti-nociceptive action.

Identification of a human estrogen receptor α tetrapeptidic fragment with dual antiproliferative and anti-nociceptive action.

Journal: Scientific reports

Published: March 31, 2022

Application of an Environmental Monitoring to Assess the Practices and Control the Risk of Occupational Exposure to Cyclophosphamide in Two Sites of a French Comprehensive Cancer Center.

Application of an Environmental Monitoring to Assess the Practices and Control the Risk of Occupational Exposure to Cyclophosphamide in Two Sites of a French Comprehensive Cancer Center.

Journal: Annals of work exposures and health

Published: July 15, 2021

Showing 1-12 of 15

Last Updated: 09/26/2026